跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) - TGA Drug Approval Details
Approvals
/
TGA
/
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated)
Approved
STANDARD
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated)
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f2d12451b2b05bad
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
f2d12451b2b05bad
Product Name
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated)
Artg Id
278660
Artg Name
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated)
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2016-08-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f2d12451b2b05bad
Type
Standard
Back to TGA Approvals